J. Reubi

发表

Alpha-versus Beta-particle Radiopeptide Therapy in a Human Prostate Cancer Model ( Bi-amba versus 177 Lu-dota-pesin)

F. Bruchertseifer, A. Morgenstern, J. Boisclair, 2022 .

Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.

J. Charboneau, C. Reading, D. Nagorney, 1990, Cancer research.

Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

P. Neuhaus, C. Ziske, B. Wiedenmann, 1996, Gut.

Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.

H. Bruining, E. Krenning, H. Pols, 1994, The American journal of medicine.

111In-octreotide scintigraphy in oncology.

E. Krenning, C. V. van Eijck, S. Lamberts, 1992, Metabolism: clinical and experimental.

The Presence of Somatostatin Receptors in Rheumatoid Arthritis

P. M. Vanhagen, H. Markusse, S. Lamberts, 1994 .

Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs.

J. Laissue, A. Kappeler, J. Reubi, 1998, Blood.

[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?

W. Wiersinga, E. Krenning, J. Reubi, 1994, The Journal of clinical endocrinology and metabolism.

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours

E. Krenning, M. Jong, J. Erion, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Noninvasive differentiation of meningiomas from other brain tumours using combined111indium-octreotide/99mtechnetium-DTPA brain scintigraphy

J. Kinser, R. Seiler, A. Barth, 2005, Acta Neurochirurgica.

Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours

E. Krenning, B. Wiedenmann, R. Arnold, 2005 .

EVIEWS IN BASIC AND CLINICAL ASTROENTEROLOGY AND HEPATOLOGY

M. Gershwin, D. Kwekkeboom, E. Heathcote, 2022 .

In vivo somatostatin receptor imaging in medullary thyroid carcinoma.

E. Krenning, S. Lamberts, J. Reubi, 1993, The Journal of clinical endocrinology and metabolism.

Somatostatin analogue scintigraphy of malignant lymphomas

E. Krenning, B. Löwenberg, W. Bakker, 1993, British journal of haematology.

Somatostatin receptors in human renal cell carcinomas.

L. Kvols, J. Reubi, J. Reubi, 1992, Cancer research.

In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue.

E. Krenning, J. Laissue, J. Reubi, 1993, Blood.

Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.

B. Waser, J. Schaer, J. Reubi, 1997, Cancer research.

Visualization of the thymus by substance P receptor scintigraphy in man

T. Visser, E. Krenning, J. Laissue, 1996, European Journal of Nuclear Medicine.

Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.

J C Reubi, J. Reubi, J. Reubi, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer

E. Krenning, M. Jong, J. Erion, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

March 2006

B. Waser, J. Schaer, J. Gillart, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo

J. Erion, J. Reubi, J. Bugaj, 1998, European Journal of Nuclear Medicine.

Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth.

B. Evers, J. Reubi, Pomila Singh, 1991, Gastroenterology.

High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents.

J. Reubi, J. Schaer, J. Reubi, 1999, The Journal of clinical endocrinology and metabolism.

Local up-regulation of neuropeptide receptors in host blood vessels around human colorectal cancers.

L. Mazzucchelli, J. Laissue, J. Reubi, 1996, Gastroenterology.

Somatostatin receptors in human prostate and prostate cancer.

J. Reubi, B. Waser, R. Markwalder, 1995, The Journal of clinical endocrinology and metabolism.

In vitro detection of somatostatin receptors in human tumors.

L. Kvols, E. Krenning, J. Reubi, 1992, Metabolism: clinical and experimental.

The Presence of Somatostatin Receptors in Rheumatoid Arthritis

E. Krenning, S. Lamberts, J. Reubi, 1994 .

Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.

T. Moody, M. Birrer, I. Gozes, 1996, Cancer Research.

Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile

B. Nock, T. Maina, P. Cordopatis, 2024, International journal of molecular sciences.

Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.

H. Friess, M. Büchler, M. Korc, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Analgesic activity of a non-peptide imidazolidinedione somatostatin agonist: In vitro and in vivo studies in rat

J. Reubi, S. Carlton, G. Ji, 2006, Pain.

Gigantism due to pituitary mammosomatotroph hyperplasia.

S. Asa, K. Kovacs, J. Reubi, 1990, The New England journal of medicine.

Somatostatin receptor scintigraphy in non-medullary thyroid cancer.

H. van Toor, E. Krenning, J. Reubi, 1996, Digestion.

Somatostatin analogs in the treatment of acromegaly.

E. Krenning, S. Lamberts, J. Reubi, 1992, Endocrinology and metabolism clinics of North America.

Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.

S. Nilsson, J. Laissue, J. Reubi, 1995, Cancer research.